1.0Neuraxpharmhttps://www.neuraxpharm.com/ukIncrentahttps://www.neuraxpharm.com/uk/blog/author/adminDisclosures – Working with Patient Organisationsrich600338<blockquote class="wp-embedded-content" data-secret="SV7KDrMbzW"><a href="https://www.neuraxpharm.com/uk/disclosures">Disclosures – Working with Patient Organisations</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://www.neuraxpharm.com/uk/disclosures/embed#?secret=SV7KDrMbzW" width="600" height="338" title="“Disclosures – Working with Patient Organisations” — Neuraxpharm" data-secret="SV7KDrMbzW" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script>
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://www.neuraxpharm.com/uk/wp-includes/js/wp-embed.min.js
</script>
This page is intended for members of the public in the UK seeking information on Neuraxpharm UK business NXUK/2025/01 | March 2026 Neuraxpharm Disclosure In line with the Association of the British Pharmaceutical Industry (ABPI) Code of Practice, our disclosure of payments to patient organisations and members of the public are published below. Neuraxpharm are […]